GDOC Among Gold ETFs
End-of-day Nov 19, 2026 · 24 Gold ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −2.9% | +0.7% | −1.3% | +7.0% | +6.4% | +30.1% | −1.8% | — | −1.8% |
| Peer average | −1.8% | −5.6% | −8.9% | −13.6% | −3.7% | +0.8% | +75.4% | +61.1% | +183.5% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$143 of every $1,000 in GDOC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.32% | $1,432.09 | 2,066 | $2.9M |
| 2 | JNJJohnson & Johnson | Healthcare | 6.22% | $621.73 | 4,548 | $1.2M |
| 3 | UNHUnitedhealth Group Incorporated | Healthcare | 5.11% | $510.79 | 2,912 | $1.0M |
| 4 | EWEdwards Lifesciences | Healthcare | 4.88% | $487.63 | 9,244 | $973K |
| 5 | MRKMerck | Healthcare | 4.70% | $470.43 | 6,811 | $938K |
| 6 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 4.06% | $406.34 | 1,511 | $811K |
| 7 | DXCMDexcom | Healthcare | 4.05% | $404.65 | 9,782 | $807K |
| 8 | AAgilent Technologies | Healthcare | 3.99% | $398.69 | 4,485 | $795K |
| 9 | TMOThermo Fisher Scientific | Healthcare | 3.87% | $386.86 | 1,114 | $772K |
| 10 | AZN.LAstrazeneca ORD | Healthcare | 3.40% | $339.84 | 3,778 | $678K |
| 11 | GHGuardant Health | Healthcare | 3.21% | $320.94 | 4,411 | $640K |
| 12 | GILDGilead Sciences | Healthcare | 3.18% | $318.17 | 3,756 | $635K |
| 13 | LONN.SWLonza Group AG | Healthcare | 3.06% | $305.61 | 771 | $610K |
| 14 | ABBVAbbvie | Healthcare | 3.01% | $301.23 | 2,101 | $601K |
| 15 | CORCencora | Healthcare | 2.83% | $282.69 | 1,619 | $564K |
of the $259B in 46 Gold ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.32% |
| 2 | JNJ | Johnson & Johnson | 6.22% |
| 3 | UNH | Unitedhealth Group Incorporated | 5.11% |
| 4 | EW | Edwards Lifesciences | 4.88% |
| 5 | MRK | Merck & | 4.70% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 4.06% |
| 7 | DXCM | Dexcom | 4.05% |
| 8 | A | Agilent Technologies | 3.99% |
| 9 | TMO | Thermo Fisher Scientific | 3.87% |
| 10 | AZN.L | Astrazeneca ORD | 3.40% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 30, 2025 | $0.11 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0058 |
| Dec 26, 2023 | Jan 2, 2024 | $0.18 |
| Sep 26, 2022 | Sep 30, 2022 | $0.0000 |